Hereditary glomus tumour (MIM 168000) or paraganglioma (PGL) is a slowly progressive disorder causing benign tumour growth predominantly in the head and neck region. Though benign in nature the tumours can lead to severe morbidity. Inheritance of PGL is autosomal dominant and is strongly modified by genomic imprinting; only a paternally transmitted PGL gene leads to symptoms. A gene for PGL has recently been mapped to 11q22.3-q23.
Abstract
Hereditary glomus tumour (MIM 168000) or paraganglioma (PGL) is a slowly progressive disorder causing benign tumour growth predominantly in the head and neck region. Though benign in nature the tumours can lead to severe morbidity. Inheritance of PGL is autosomal dominant and is strongly modified by genomic imprinting; only a paternally transmitted PGL gene leads to symptoms. A gene for PGL has recently been mapped to 11q22. 3-q23 .
Genetic counselling on the basis of DNA linkage diagnosis was offered in an extended Dutch pedigree. Thirty-two subjects opted for further counselling, of whom 20 applied for DNA testing and participated in a standardised protocol. Sixteen cases had presymptomatic testing (paternal allele); four of these appeared to have the at risk haplotype and in two of them a glomus tumour was subsequently detected on MRI. In one case linkage results were inconclusive (recombination) and one person did not want to learn his test result. Four cases had testing for carrier status (maternal allele) of which one appeared to be a carrier.
Our data show that genetic counselling gains significant accuracy when based on parent of origin, sex of the counsellee, and DNA linkage diagnosis. Moreover, a normal DNA result may prevent unnecessary worry and investigations, while an established presymptomatic diagnosis will guide adequate clinical management. The psychological impact of counselling and predictive DNA testing is unclear as yet. Further investigations into the natural history of PGL in gene carriers and into the psychological impact of DNA testing is desirable (J7Med Genet 1996; 33:379-383) Key words: paragangliomas; predictive testing; genomic imprinting.
Tumour growth in the paraganglia tissue of the head and neck (for example, carotid bodies, jugular bodies, vagal bodies) is a rare disorder affecting around 1 in 100 000 people. '2 Pooled Dutch data from pathological laboratories show a mean incidence of 17 (operated) cases a year (1986) (1987) (1988) (1989) (1990) (1991) (1992) The people who opted for DNA testing were counselled according to a certain protocol and were asked to participate in a psychological study consisting of several questionnaires and sessions with a psychologist before and after DNA testing. The design of the study was approved by the local ethical committee.
COUNSELLING PROTOCOL
The counselling procedure was designed as a multidisciplinary approach involving the Departments of Clinical Genetics, Human Genetics, and Otorhinolaryngology (table 1) . At the first session the family histories were recorded and the clinical picture of PGL and the mode of inheritance was explained. Furthermore the procedure of DNA testing was explained and a prior risk was Results Sixty-eight people returned the form in which they could indicate whether they wanted further counselling or not. Thirty-six people refrained from further genetic counselling and DNA analysis. Five of these were clinically affected with PGL, 10 were potential carriers of a maternally derived allele, four were at risk of PGL (paternal allele), and in 17 their status was unknown.
Thirty-two out of 68 people (47%) opted for genetic counselling. Five patients were clinically affected and received extensive genetic counselling without the need for molecular diagnosis. The remaining 27 persons were not affected as far as they knew; 20 were at risk for a paternal PGL allele and seven for a maternal allele. Of these 27 cases, 23 were seen at the Department of Clinical Genetics, and the remaining four cases learned their result in an indirect way because their parent at risk was among the people tested and proved not to carry the PGL gene.
In the 23 symptom free cases seen, the closest affected relative according to family history was first degree in 18 cases, second degree in three cases, and third degree in two cases. Deafness and facial palsy/asymmetry are the symptoms of PGL that counsellees refer to as the clinical picture, but hoarseness, postsurgical mutilation, and death are also mentioned. The perception of the severity of PGL depended on the clinical picture of known affected relatives.
Of the 23 symptom free cases, three counsellees (two at disease risk, one potential carrier) refrained from further investigations after the intake session. In 20 symptom free cases, DNA linkage diagnosis has been performed (table 2) . For all these cases a prior risk of carrying the PGL gene was determined (table  2) . For those at risk of a paternally derived gene we used the age at first symptom curve as determined in the Leiden patient set by Jansen et al. '8 Of the 20 DNA diagnoses in 16 cases this concerned presymptomatic testing (paternal transmission). Four cases appeared to be gene carriers, 10 are non-carriers, one DNA result is inconclusive owing to a recombination event, and one person refrained from learning the test result. This man feared he could not cope with the feelings of guilt towards his children if he turned out to be a gene carrier. The four positive results increased the prior risk for four children to 50%, two potential maternal and two potential paternal transmissions. The eight negative results provided a result for over 11 children who were in a 25% at risk situation that now changed to <0-1%, that is the population risk of isolated PGL. This concerned a potential paternal transmission in eight cases and a potential maternal transmission in three cases.
In four cases DNA diagnosis was performed for carrier testing (maternal transmission). In these cases their actual age does not affect the prior chance of carriership. One person appeared to be a gene carrier, which increased the prior risk of four children to 50% of inheriting a maternal allele. Three cases were non-carriers, two female and one male. This made the risk of inheriting a maternal allele for eight children and a paternal allele for six children negligible.
Four counsellees, three who received a positive DNA result and the one case with an uninformative DNA result, visited the ENT outpatients clinic for further counselling (table  2) . They were examined physically by the ENT surgeon and had an MRI investigation. Two out of three showed a tumour of the glomus caroticum (one of them, 1-61, was operated upon), one was negative on MRI. The case with the recombination had a normal MRI five years ago and now again shows no abnormalities on MRI.
Discussion
Paraganglioma is a relatively benign disorder leading to tumour growth in the head and neck region. According to published reports, at least 5% is hereditary; in our geographical region more than 50% appear familial and in these families genetic counselling should be offered. It is our experience that thorough family history data are needed before it can be concluded that a case is sporadic, because ofthe sometimes very mild symptoms in key relatives or the skipping of generations owing to genomic imprinting or both. This is illustrated by the fact that of our 20 people with a risk of 50% (at birth) of inheriting the PGL gene, two have a third degree and three have a second degree relative as the closest relative known to be clinically affected. Moreover, as in many other well known genetic tumour susceptibility syndromes, sporadic PGL cases with multiple tumours are suspected to be the result of an inherited mutation. 25 Of performed, only one case turned out to be uninformative owing to a recombination event in the PGL region. In all other cases the DNA result had a certainty of over 99 9% since the chance of a double recombinant between the PGL locus and both flanking markers is very low. '9 It is evident that genetic counselling and risk estimation are much more specific when based on parental origin of the PGL gene and on DNA diagnosis using flanking polymorphic markers. For people at risk of a paternal PGL gene the reliability of a DNA diagnosis performed once is age independent, less burdensome than (regular) MRI or angiography, and less expensive than most other procedures. DNA diagnosis is in fact the only way a person at risk for a maternal PGL gene can learn his or her status, unless the disease has already manifested itself in affected offspring. This DNA carrier diagnosis for an autosomal dominant disorder with no consequences for the "patient's" health, even at a young age, is unusual in clinical genetics. It 
